Medical Companies Address Chronic And Acute Pain Market, Reaching $151.7 Billion By 2030, With Variety Of Treatments: Electrotherapy, Device-Based Medical Therapies, OTC And Prescription-Drug Pharmaceuticals As COVID-19 Pandemic Heightens Global Opioid Crisis
By
In NASDAQ: AXSM, NYSE: ABT, NYSE: BMY, NYSE: BSX, NYSE: GSK, NYSE: JNJ, NYSE: LLY, NYSE: MDT, NYSE: NVRO, NYSE: NVS, OTCQB: EMED
Posted

Medical Companies Address Chronic And Acute Pain Market, Reaching $151.7 Billion By 2030, With Variety Of Treatments: Electrotherapy, Device-Based Medical Therapies, OTC And Prescription-Drug Pharmaceuticals As COVID-19 Pandemic Heightens Global Opioid Crisis

Medical company leaders in the chronic and acute pain market are addressing these issues with diverse treatments: from electrotherapy devices to OTC and prescription-drug pharmaceuticals. A new [...]

READ MORE
Medical Companies Address Chronic And Acute Pain Market, Reaching $151.7 Billion By 2030, With Variety Of Treatments: Electrotherapy, Device-Based Medical Therapies, OTC And Prescription-Drug Pharmaceuticals As COVID-19 Pandemic Heightens Global Opioid Crisis
By
In NASDAQ: AXSM, NYSE: ABT, NYSE: BMY, NYSE: BSX, NYSE: GSK, NYSE: JNJ, NYSE: LLY, NYSE: MDT, NYSE: NVRO, NYSE: NVS, OTCQB: EMED
Posted

Medical Companies Address Chronic And Acute Pain Market, Reaching $151.7 Billion By 2030, With Variety Of Treatments: Electrotherapy, Device-Based Medical Therapies, OTC And Prescription-Drug Pharmaceuticals As COVID-19 Pandemic Heightens Global Opioid Crisis

Medical company leaders in the chronic and acute pain market are addressing these issues with diverse treatments: from electrotherapy devices to OTC and prescription-drug pharmaceuticals. A new [...]

READ MORE
Electromedical Technologies, Inc. (OTCQB: EMED) Positioned For The Future With WellnessPro™Plus And Planned Wellness Pro® Pod With ‘Future-Ready’ FDA-Cleared Device That Treats Chronic And Acute Pain; EMED Addresses Opioid Abuse Market And $151.7 Billion Chronic Pain Market Seen By 2030
By
In NASDAQ: AXSM, NYSE: ABT, NYSE: BMY, NYSE: BSX, NYSE: GSK, NYSE: MDT, NYSE: NVRO, NYSE: NVS, OTCQB: EMED
Posted

Electromedical Technologies, Inc. (OTCQB: EMED) Positioned For The Future With WellnessPro™Plus And Planned Wellness Pro® Pod With ‘Future-Ready’ FDA-Cleared Device That Treats Chronic And Acute Pain; EMED Addresses Opioid Abuse Market And $151.7 Billion Chronic Pain Market Seen By 2030

Electromedical Technologies, Inc. (OTCQB: EMED) is positioned for the future. The company, recently up listed to the OTCQB market, is fighting opioid abuse with its FDA-cleared WellnessPro™ [...]

READ MORE